cbdMD, Inc. (YCBD): Entry into a Material Definitive Agreement

cbdMD, Inc. (YCBD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women ’ s Beauty, Weight Loss and Longevity Wellness Agreement will add iconic supplement brands to cbdMD ’ s growing multi-brand consumer wellness platf

Event · M&A · definitive agreement
Role
acquirer
Counterparty
Twinlab

Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.

Original reporting
Published Sep 2, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 11:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$YCBD
Bullish
high confidence
Mentioned
$YCBD
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$YCBDBullishMed
01

Why it matters

The deal adds recognizable brands, reduces revenue concentration, and targets a broader wellness market, potentially improving valuation multiples.

02

Market read

First‑report of a material M&A transaction for a small‑cap wellness firm, likely to move the stock as investors price in diversification and growth potential.

03

What to watch

Court approval of the ABC process and execution of integration may delay benefits.

Relevance 6/10Novelty 7/10Timing: filing today

Background

cbdMD, a NYSE American listed consumer wellness company, is expanding beyond its hemp focus by acquiring Twinlab’s supplement portfolio.

Company-level read

Ticker impact

$YCBDBullishHigh confidence
Context

cbdMD filed an 8‑K announcing a definitive asset purchase agreement to acquire Twinlab’s operating assets and brands, expanding revenue to about $30 million.

Expected impact

Potential upside as market prices in the expanded product portfolio and reduced concentration risk.

Evidence & confidence

First‑report M&A disclosure with clear revenue impact; investors typically reward diversification and brand additions.

Market effects

Strengthens the consumer wellness and supplement sector by consolidating legacy brands under a modern e‑commerce platform.

U.S. market, particularly health‑and‑wellness retailers and distributors.

Limited to U.S. investors; no immediate global macro effect.

Counterpoint

Integration risks and potential overpay for legacy brands could dilute margins.

Key entities

  • cbdMD, Inc.

    Acquirer, listed on NYSE American under ticker YCBD.

  • Twinlab

    Seller of legacy supplement brands including Reserveage, Metabolife, Alvita Tea.

Related articles

$IONSHighAI 9/10

Weekly Buzz: IONS, MIST, BIIB, AZN Win Nods; TCRX, NVS Cut Jobs; OVID, VIR Data; REGN, PASG Deals

Ionis (IONS) and Milestone (MIST) gained FDA approvals for neurology and cardiology drugs. Biogen (BIIB) and AstraZeneca (AZN) also received regulatory nods for Alzheimer's and cancer treatments. Novavax (NVAX) secured global approvals for its COVID-19 vaccine. TScan (TCRX) and Novartis (NVS) announced job cuts. Novartis (NVS) and HUTCHMED (HCM) struck deals worth up to $3.2B and $1.295B respectively.

$YCBDMed

cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026

cbdMD, Inc. (NYSE American: YCBD) reported Q3 FY2026 results ended June 30, 2026. Revenue rose 20% year over year to $5.6 million, driven by 61% higher wholesale net sales and a full quarter contribution from Bluebird Botanicals. Oasis distribution expanded. Loss from operations was about $1.13 million. The company cited federal hemp legislation timing and expected monthly cost savings up to $150,000.

$PLCEMed

The Children’s Place begins nationwide closing sales as the future of hundreds of stores remains uncertain

The Children's Place has begun nationwide closing sales across its 500 stores in the U.S. and Canada, following a Chapter 11 bankruptcy filing. The retailer is seeking a buyer to potentially preserve operations. Gymboree, also owned by the company, is included in the liquidation. Sales are ongoing in stores and online, with gift cards and rewards valid until Dec. 12, 2026. The company aims to complete the sale process by the end of December, but the future of stores and brands remains uncertain.

$SNTMed

Insurer Santam Grows 10% as Returns Slip

Santam, a South African insurer, reported 10% growth in premiums for the nine months ending September 2026, but investment returns fell to 2.5% from 3% due to weaker markets. The company's underwriting margin improved since June, staying within its 5%-10% target. Sanlam, which holds 63% of Santam, offered R505 per share to acquire the remaining shares, with the deal expected to close in Q1 2027. Santam's share price is currently 2.8% below the offer price.